Follow
Jozsef Szasz
Jozsef Szasz
Assoc Prof, University of Medicine and Pharmacy Tirgu Mures
Verified email at umfst.ro
Title
Cited by
Cited by
Year
Randomized trial of safinamide add‐on to levodopa in Parkinson's disease with motor fluctuations
R Borgohain, J Szász, P Stanzione, C Meshram, M Bhatt, D Chirilineau, ...
Movement Disorders 29 (2), 229-237, 2014
2982014
Two‐year, randomized, controlled study of safinamide as add‐on to levodopa in mid to late Parkinson's disease
R Borgohain, J Szasz, P Stanzione, C Meshram, MH Bhatt, D Chirilineau, ...
Movement Disorders 29 (10), 1273-1280, 2014
2562014
Levodopa-carbidopa intestinal gel in advanced Parkinson's: final results of the GLORIA registry
A Antonini, W Poewe, KR Chaudhuri, R Jech, B Pickut, Z Pirtošek, J Szasz, ...
Parkinsonism & related disorders 45, 13-20, 2017
1882017
Factors influencing hemorrhagic transformation in ischemic stroke: a clinicopathological comparison
L Kerenyi, L Kardos, J Szász, S Szatmári, D Bereczki, K Hegedüs, L Csiba
European journal of neurology 13 (11), 1251-1255, 2006
1192006
The effect of levodopa–carbidopa intestinal gel infusion long-term therapy on motor complications in advanced Parkinson’s disease: a multicenter Romanian experience
O Băjenaru, A Ene, BO Popescu, JA Szasz, M Sabău, DF Mureşan, ...
Journal of Neural Transmission 123, 407-414, 2016
492016
Neuroinflammation and microglia/macrophage phenotype modulate the molecular background of post-stroke depression: A literature review
EE Nagy, A Frigy, JA Szász, E Horváth
Experimental and therapeutic medicine 20 (3), 2510-2523, 2020
432020
Prestroke alcohol consumption and smoking are not associated with stroke severity, disability at discharge, and case fatality
K Fekete, S Szatmári, I Szőcs, C Szekeres, J Szász, L Mihálka, ...
Journal of Stroke and Cerebrovascular Diseases 23 (1), e31-e37, 2014
332014
Concomitant medication usage with levodopa‐carbidopa intestinal gel: results from the COSMOS study
A Fasano, T Gurevich, R Jech, N Kovács, P Svenningsson, J Szász, ...
Movement Disorders 36 (8), 1853-1862, 2021
302021
Profile of patients with advanced Parkinson’s disease suitable for device-aided therapies: restrospective data of a large cohort of Romanian patients
JA Szász, VA Constantin, K Orbán-Kis, A Rácz, LA Bancu, D Georgescu, ...
Neuropsychiatric Disease and Treatment, 3187-3195, 2019
252019
Levodopa-carbidopa intestinal gel infusion therapy discontinuation: A ten-year retrospective analysis of 204 treated patients
VA Constantin, JA Szász, K Orbán-Kis, EC Rosca, M Popovici, A Cornea, ...
Neuropsychiatric Disease and Treatment, 1835-1844, 2020
212020
Therapeutic strategies in the early stages of Parkinson’s disease: a cross-sectional evaluation of 15 years’ experience with a large cohort of Romanian patients
JA Szász, K Orbán-Kis, VA Constantin, C Péter, I Bíró, I Mihály, K Szegedi, ...
Neuropsychiatric Disease and Treatment, 831-838, 2019
202019
The role of selective monoamine oxidase B inhibitors in the therapeutic strategy of Parkinson's disease in the neurology clinics of Tirgu Mures County Emergency Clinical Hospital
JA Szász, V Constantin, PA Fazakas, E Blényesi, LG Grieb, A Balla, ...
Orvosi Hetilap 158 (51), 2023-2028, 2017
182017
Dopamine agonists in Parkinson's disease therapy-15 years of experience of the Neurological Clinics from Tîrgu Mureș. A cross-sectional study
JA Szász, C Viorelia, I Mihály, I Biró, C Péter, K Orbán-Kis, S Szatmári
Ideggyogyaszati Szemle 72 (5-6), 187-193, 2019
162019
Characteristics of levodopa treatment in advanced Parkinson's disease in the experiences of the neurology clinics of Târgu Mureș, Romania
JA Szász, S Szatmári, V Constantin, I Mihály, A Rácz, LC Domokos, ...
Orvosi Hetilap 160 (17), 662-669, 2019
152019
The Mureş–Uzhgorod–Debrecen study: a comparison of hospital stroke services in Central‐Eastern Europe
S Szatmári, I Pascu, L Mihálka, SV Mulesa, I Fekete, B Fülesdi, L Csiba, ...
European Journal of Neurology 9 (3), 293-296, 2002
132002
Characterizing advanced Parkinson’s disease: Romanian subanalysis from the OBSERVE-PD study
JA Szasz, DC Jianu, MA Simu, VA Constantin, AO Dulamea, K Onuk, ...
Parkinson’s Disease 2021, 2021
122021
Management challenges of severe, complex dyskinesia. Data from a large cohort of patients treated with Levodopa-carbidopa intestinal gel for advanced Parkinson’s disease
JA Szász, VA Constantin, K Orbán-Kis, LA Bancu, M Ciorba, I Mihály, ...
Brain Sciences 11 (7), 826, 2021
102021
Long‐term safety and tolerability of lacosamide monotherapy in patients with epilepsy: Results from a multicenter, open‐label trial
E Ben‐Menachem, J Dominguez, J Szász, C Beller, C Howerton, ...
Epilepsia Open 6 (3), 618-623, 2021
92021
The importance of evaluation of gastrointestinal symptoms in advanced Parkinson’s disease
J Szász, S Szatmári, V Constantin, I Mihály, A Rácz, I Török, E Nagy, ...
Orvosi hetilap 161 (39), 1681-1687, 2020
92020
Motor and nonmotor symptoms in patients treated with 24-hour daily levodopa-carbidopa intestinal gel infusion: Analysis of the COmedication Study assessing Mono-and cOmbination …
N Kovács, J Szász, L Vela-Desojo, P Svenningsson, S Femia, JC Parra, ...
Parkinsonism & Related Disorders 105, 139-144, 2022
72022
The system can't perform the operation now. Try again later.
Articles 1–20